论文部分内容阅读
Skin toxicity is a common symptom of anti-epidermal growth factor receptor （EGFR） antibody treatment andis also a predictive marker of its efficacy in colorectalcancer patients. However, severe skin disorders inducedby such antibodies negatively impact on